Supplier profile
Mape+Tzin Sa de Cv
Every public-sector award we hold for this supplier, across Mexico.
Awards won
864
all time
Attributed value
MXN 987.1m
as published
Buyers
0
public bodies
Active
—
first to latest award
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| No named buyers. | ||
What they win
Awards
Showing 726–750 of 864 awards we hold
- P-Gb-048 2023 ↗£37k
- Adquisición de Medicamentos y Material de Curacion de Consolidada Licitacion, Para Farmacia Hospitalaria y Farmacia Gratuidad 2023-2024 ↗£815
- Materiales,Accesorios y Suministros Medicos ↗£81k
- Adquisición de Material de Curación ↗£49k
- Aa-050Gyr017-E16-2019 Adquisición de Claves de Los Grupos de Suministro 060 Mat ↗£8k
- Aa-050Gyr009-E285-2020 Adq Material de Curacion ↗£22k
- Aa-050Gyr035-E340-2019 Adjudicacion Directa Medicamentos y Mat de Curacion. ↗£28k
- Ia-050Gyr009-E658-2019 Adq y Sum de Material de Curacion Rca 680 ↗£6k
- Aa-050Gyr022-E376-2021 Adquis. 147 Claves Grupo 060 Material de Curación ↗£7k
- Aa-050Gyr033-E409-2019 Adq de Artículos de Consumo Terapéutico Grupo 010-080 ↗£19k
- La-12-M7B-012M7B997-I-1-2023 Medicamentos y Material de Curación ↗£22.1m
- Aa-050Gyr009-E18-2020 Adq y Sum de Material de Curacion Ref 64 ↗£17k
- Adquisición Consolidada de Material de Curación, Agentes de Diagnóstico y Otros Insumos Para Los Ejercicios 2023-2024. 394 Claves 2ª Vuelta (86 Claves) Licitación Pública Internacional Abierta La-012M7B997-E146-2022 ↗£83k
- Aa-050Gyr014-E211-2021 Adquisicion de Material de Curacion ↗£162k
- S18/Ad/180/2021 Mat. Curación. Radiológico, Laboratorio 2Da V ↗£3k
- Aa-051Gyn013-E51-2022 Adj. Dcta. 4 Claves Mat. Curación ↗£49k
- Aa-050Gyr014-E109-2020 Adquisicion de Material de Curacion ↗£24k
- Aa-050Gyr005-E385-2020 Adq de Medicamento y Material de Curacion ↗£2k
- Aa-050Gyr006-E526-2019 Material de Curación y Laboratorio ↗£36k
- Ia-050Gyr009-E206-2021 Material de Curacion Radiologico y Laboratorio (0636) ↗£197k
- Aa-050Gyr010-E192-2020 Material de Curacion y de Laboratorio ↗£41k
- Adquisición Consolidada de Material de Curación, Agentes de Diagnostico y Otros Insumos Para Los Ejercicios 2023-2024, (394 Claves 2ª Vuelta 86 Claves) Para la Farmacia Hospitalaria Para el Hospital Regional de Alta Especialidad Ciudad Salud ↗£259k
- Aa-050Gyr033-E154-2020 Bienes Terapeuticos Grupos 010, 040, 060, 070 y 080 ↗£12k
- Contratación Consolidada Para la Adquisición de Material de Curación, Laboratori ↗£26k
- Relativa a la Adquisición de Equipo E Instrumental Medico y de Laboratorio Para ↗£1.2m
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.